Nav: Home

Researchers find diminished response by 'killer' T cells in elderly COVID-19 patients

September 21, 2020

WASHINGTON, D.C. - September 21, 2020 - Although people of any age can become infected with SARS-CoV-2, the virus that causes COVID-19, elderly patients face a higher risk of severity and death than younger patients. New research comparing the immune response among age groups, published this week in mBio, an open-access journal of the American Society for Microbiology, may help explain why. Older patients with the disease have lower frequencies of the immune cells needed to expel the virus from the body, the researchers found.

"Elderly people have more severe diseases compared to young people, and we found that the cytotoxic part of immune control is not as efficient to respond to the virus in older people," said virologist Gennadiy Zelinskyy, Ph.D., at the University Hospital Essen, in Germany. Zelinskyy led the new study.

He and his colleagues analyzed blood samples from 30 people with mild cases of COVID-19 to observe how T cells, which are necessary for recognition and elimination of infected cells, respond during SARS-CoV-2 infection. Patient ages ranged from the mid-20s to the late 90s. In all patients, the investigators found that acute SARS-CoV-2 infections led to lower numbers of T cells in the blood of the patients, compared to healthy individuals.

This reduction has been one of many unwelcome surprises from COVID-19, said Zelinskyy. Most viruses, once inside the body, trigger an uptick in the immune system's expansion of T cells. These include "killer" T cells, which play a critical role in eradicating virus-infected cells. They produce cytotoxic molecules that destroy infected cells in the body. But if a person's immune system produces fewer of these T cells, said Zelinskyy, it will be less successful at fighting off a viral infection.

In the COVID-19 patient group studied by Zelinskyy and his colleagues, the researchers similarly found that the number of CD8+ T cells producing cytotoxic molecules in response to virus diminished with increased age, and that reduction was significantly higher, on average, in patients over 80. Moreover, the "killer" T cells from patients aged 80-96 produced cytotoxic molecules at a lower frequency than similar cells from younger patients.

The SARS-CoV-2 virus attaches to cells in the nose or mouth. From there, it may spread to the lungs and move on to other organs, triggering a life-threatening infection. "Cytotoxic T cells really fight for control during this acute phase of infection," Zelinskyy said. If an elderly patient's immune system produces fewer killer T cells, and these cells are inadequately armed, he said, they may be mounting an insufficient defense against SARS-CoV-2. The viral particles can continue to spread and, as a result, the infection worsens.

The new data suggest that cytotoxic T cells play a key role in control of early infections, but Zelinskyy cautioned that it's too soon to know if that connection can be harnessed to design an effective immunotherapy that uses these cells. In previous studies on viral infections in mice, his group found that a checkpoint inhibitor--an immunotherapy that activates killer T cells and effectively releases the brakes on the immune system--improved virus control at first but had the potential to later cause damage to the lungs and other organs. Further studies are warranted, he said, to better understand the potential risks and benefits of interfering with T cells as a way to control SARS-CoV-2 and other viruses.
-end-
The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of 30,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.

ASM advances the microbial sciences through conferences, publications, certifications, educational opportunities and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.

American Society for Microbiology

Related Immune System Articles:

Memory training for the immune system
The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen.
Immune system may have another job -- combatting depression
An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects.
COVID-19: Immune system derails
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.
Immune cell steroids help tumours suppress the immune system, offering new drug targets
Tumours found to evade the immune system by telling immune cells to produce immunosuppressive steroids.
Immune system -- Knocked off balance
Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune diseases and allergies.
Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.
Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.
How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.
Immune system upgrade
Theoretically, our immune system could detect and kill cancer cells.
Using the immune system as a defence against cancer
Research published today in the British Journal of Cancer has found that a naturally occurring molecule and a component of the immune system that can successfully target and kill cancer cells, can also encourage immunity against cancer resurgence.
More Immune System News and Immune System Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.